Clinical trial
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
NCT07543757
Study timeline
Study start (actual)2026-04-03Date precision: day
Registry last updated2026-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancer Detectionunresolved
Interventions
ProclarixDIAGNOSTIC_TEST
Sponsors & collaborators
Sequenom, Inc.lead sponsor
Labcorp Corporation of America Holdings, Inccollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07543757 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.